Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06316349
Other study ID # CAAE: 75727323.3.0000.0068
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 18, 2024
Est. completion date March 18, 2026

Study information

Verified date June 2024
Source University of Sao Paulo General Hospital
Contact Rafael M Ianotti, PT
Phone +55 11 26615319
Email rafael.ianotti@hc.fm.usp.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this randomized clinical trial is to compare the effects of a standardized exercise program alone versus the same program combined with neuromuscular electrical stimulation in patients undergoing heart failure . The main questions it aims to answer are: - Assessing the ultrasonographic parameters: echo intensity (echogenicity), cross-sectional area, thickness, and pennation angle of the rectus femoris muscle in both lower limbs. - Evaluating the strength of the femoral quadriceps muscle - Evaluating the changes in the chronaxie of the rectus femoris muscle in both lower limbs. The protocol will have a total duration of 35 days, with an initial intervention period of 21 days (5 days per week), followed by a 14-day follow-up period.


Description:

- Introduction: Patients with refractory heart failure who develop cardiogenic shock may require the use of an intra aortic balloon pump. This device, when inserted through the femoral artery, necessitates bed rest and increases the incidence of muscle mass loss. Rehabilitation programs in the intensive care unit that include resistive training bring benefits such as improving muscle architecture, strength, and function. Neuromuscular electrical stimulation (NMES) can be an important tool to assess excitability and improve muscle strength through muscle contractions generated by motor axon depolarization. Muscle ultrasonography is currently used as a tool for evaluating and monitoring muscle architecture (echointensity) and mass. - Objectives: To evaluate the effect of combining NMES with a standardized exercise program on the echointensity (echogenicity) of the rectus femoris muscle in hemodynamically stable patients using an intra aortic balloon pump. - Method: This is a randomized controlled clinical trial comparing two groups: one group will perform resisted knee extension exercises in both lower limbs, while the other group will perform the same exercises synchronously with NMES of the femoral quadriceps muscle. The resistance load will be determined by the one-repetition maximum test and adjusted if necessary. The intervention period will be 21 days (5 days/week) with a follow-up of 14 days. Muscle architecture and mass (ultrasonography), neuromuscular excitability (using the same NMES device), and knee extension strength (dynamometry) will be assessed at baseline, on the 14th, 21st, and 35th days.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date March 18, 2026
Est. primary completion date March 18, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age = 18 years - Intra-aortic balloon pump (IABP) for more than 48 hours - Dobutamine = 20 mcg/kg/min - Norepinephrine = 0.2 mcg/kg/min (35) - Absence of device failures or bleeding in the last 24 hours - Mean arterial pressure (MAP) = 60 mmHg and = 120 mmHg - Heart rate (HR) = 60 bpm and = 120 bpm - Absence of neurological event with previous cognitive or motor deficit - Presence of untreated deep venous thrombosis - Absence of previous autoimmune diseases - Absence of previous rheumatic diseases Protocol Discontinuation Criteria: - Need for norepinephrine > 0.2 mcg/kg/min - Acute arrhythmia of any etiology with hemodynamic instability - Hemodynamic instability: MAP < 60 mmHg or >120 mmHg or HR < 60 bpm or > 120 bpm - Occurrence of neurological event with cognitive or motor deficit Exclusion Criteria: - Need for invasive mechanical ventilatory support - If the patient or responsible family member fails to sign or withdraws the informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Isolated Resistance Training Program
The hip range of motion (ROM) will be fixed at 45 degrees due to the limitation imposed by the femoral insertion of the intra-aortic balloon pump in both lower limbs to allow for a 45-degree knee extension ROM. Four sets of 10 knee extension repetitions will be performed with a 90-second rest interval between sets. The intensity (resistive load) will be set at 60% of the baseline load, calculated using the one-repetition maximum (1RM) test and adjusted weekly if necessary.
Neuromuscular electrical stimulation
For NMES, two electrodes (area of 5 x 9 cm) will be positioned perpendicular to the muscles of the femoral quadriceps. The parameters of NMES will remain fixed throughout the study: pulsed, biphasic current, with a frequency of 35Hz, pulse width of 1000µs, on-time of 7 seconds (with 3 seconds of rise, 1 second of sustainment, and 3 seconds of descent), and off-time switched off. These settings allow the onset of NMES to be synchronous with the start and end of hip extension for simultaneous execution with resistance exercises and a total of 40 stimulations. The intensity will be gradually adjusted until evoked contractions of grade 4 to 5 (partial muscle recruitment and total muscle recruitment) or the maximum intensity tolerated by the patient is achieved.

Locations

Country Name City State
Brazil Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo General Hospital

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary To investigate echo intensity of the rectus femoris muscle. The ultrasonographic images will be obtained by a portable device in B-mode, using a 6 cm linear array transducer with a frequency range of 6-13MHz. The echointensity value will be acquired through quantitative analysis using the square method, in grayscale, where the average value will be calculated using the histogram function of the dedicated software, in arbitrary units (AU). The data will be collected on the day of protocol initiation (Day 0), after 14 days (Day 14), 21 days (Day 21), and 35 days (Day 35).
Secondary To investigate cross-sectional area of the rectus femoris muscle. The cross-sectional area will be determined by the number and size of individual fibers within the rectus femoris muscle, using the measurement of the anatomical area (cross section of a muscle perpendicular to its longitudinal axis) in centimeters square. The data will be collected on the day of protocol initiation (Day 0), after 14 days (Day 14), 21 days (Day 21), and 35 days (Day 35).
Secondary To investigate pennation angle of the rectus femoris muscle. The pennation angle will be calculated by the intersection of the path between the fascia with the lower aponeurosis of the rectus femoris muscle, measured in degrees. The data will be collected on the day of protocol initiation (Day 0), after 14 days (Day 14), 21 days (Day 21), and 35 days (Day 35).
Secondary To investigate changes in quadriceps femoral muscle strength. It will be obtained using digital dynamometry through 3 measurements, with a one-minute interval, and the highest obtained value will be considered, measured in Newtons (N). The data will be collected on the day of protocol initiation (Day 0), after 14 days (Day 14), 21 days (Day 21), and 35 days (Day 35).
Secondary To investigate changes in arterial blood pressure during the protocol. Assessed by blood pressure measured by intra aortic baloon pump. Immediately before and after the end of the protocol.
Secondary To investigate changes in heart rate during the protocol. Measured by invasive blood pressure monitoring. Immediately before and after the end of the protocol.
Secondary To investigate changes in peripheral oxygen saturation during the protocol. Measured by pulse oximetry. Immediately before and after the end of the protocol.
Secondary To investigate changes in the veno-arterial difference in carbon dioxide partial pressure. Measured by blood gas analysis sample. Immediately before and after the end of the protocol.
Secondary To investigate adverse events: Bleeding at the femoral insertion or changes in the functioning of the IABP, occurrence of acute arrhythmia or hemodynamic instability ( MAP < 60 mmHg or >120 mmHg or HR < 60 bpm or > 120 bpm). In each intervention period (5 days a week for 21 days).
See also
  Status Clinical Trial Phase
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy